Pfizer plans to ready hybrid shot to protect against omicron by March, says CEO BourlaMarket Watch • 01/11/22
Pfizer Inc. (PFE) Management Presents at 40th Annual J.P. Morgan Healthcare Conference (Transcript)Seeking Alpha • 01/11/22
Chile Latest Country To Roll Out 4th Covid Vaccine Shots — But Pfizer CEO Still Unsure Whether They're NecessaryForbes • 01/10/22
Exclusive: Pfizer plans to start human studies of its Omicron-specific COVID-19 vaccine before the end of JanuaryBusiness Insider • 01/10/22
Pfizer announces deal worth up to $1.3 billion with Beam; Beam's stock is up 4.9%Market Watch • 01/10/22
Pfizer, Beam Ink Multi-Target Research Collaboration For In Vivo Base Editing ProgramsBenzinga • 01/10/22
Pfizer Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and TherapeuticsBusiness Wire • 01/10/22
Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo Base Editing Programs for a Range of Rare DiseasesBusiness Wire • 01/10/22
Pfizer Covid vaccine protects adolescents against multisystem inflammatory syndrome, CDC saysCNBC • 01/07/22
Pfizer Inc. (PFE) CEO Dr. Albert Bourla Presents at Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference (Transcript)Seeking Alpha • 01/06/22
Pfizer's Codex DNA Deal Hints At Lucrative Pivot To mRNA - Keep An Eye On This SpaceSeeking Alpha • 01/06/22